Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | CD69 | Q07108 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.48 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.48 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.48 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29013440 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL18700558 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL29735890 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL18710872 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL7152633 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL5679031 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL15334201 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL317138 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL22410446 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL1521416 | 1.00 | ALDH1A1 (0.61) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2612148-B1 | BACTERICIDAL ANTIBODY ASSAYS TO ASSESS IMMUNOGENICITY AND POTENCY OF MENINGOCOCCAL CAPSULAR SACCHARIDE VACCINES | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2019-06-12 | — | — | EP | claimed |
| US-12180527-B2 | Method for removal of impurities from bacterial capsular polysaccharide based preparations | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2024-12-31 | — | — | US | disclosed |
| US-20240400411-A1 | Method for the Manufacture of Cathode Materials | SYLVATEX, INC. (US) | 2024-12-05 | — | — | US | disclosed |
| US-20240026405-A1 | Method for Removal of Impurities from Bacterial Capsular Polysaccharide Based Preparations | SERUM INSTITUTE OF INDIA PVT LTD (IN) | 2024-01-25 | — | — | US | disclosed |
| US-11739356-B2 | Method for removal of impurities from bacterial capsular polysaccharide based preparations | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2023-08-29 | — | — | US | disclosed |
| US-20200190549-A1 | Method for Removal of Impurities from Bacterial Capsular Polysaccharide Based Preparations | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2020-06-18 | — | — | US | disclosed |
| EP-3619241-A1 | METHOD FOR REMOVAL OF IMPURITIES FROM BACTERIAL CAPSULAR POLYSACCHARIDE BASED PREPARATIONS | Serum Institute Of India Private Limited (IN) | 2020-03-11 | — | — | EP | disclosed |
| WO-2018203268-A1 | METHOD FOR REMOVAL OF IMPURITIES FROM BACTERIAL CAPSULAR POLYSACCHARIDE BASED PREPARATIONS | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2018-11-08 | — | — | WO | disclosed |